Making the most of rodent tumour systems in cancer drug discovery

被引:6
作者
Bibby, MC [1 ]
机构
[1] Univ Bradford, Clin Oncol Unit, Bradford BD7 1DP, W Yorkshire, England
关键词
D O I
10.1038/sj.bjc.6690261
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:1633 / 1640
页数:8
相关论文
共 79 条
[1]   Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model [J].
Arap, W ;
Pasqualini, R ;
Ruoslahti, E .
SCIENCE, 1998, 279 (5349) :377-380
[2]  
ATASSI G, 1985, EUR J MED CHEM, V20, P393
[3]  
ATWELL GJ, 1989, ANTI-CANCER DRUG DES, V4, P161
[4]   TUMOR VASCULATURE - A POTENTIAL THERAPEUTIC TARGET [J].
BAILLIE, CT ;
WINSLET, MC ;
BRADLEY, NJ .
BRITISH JOURNAL OF CANCER, 1995, 72 (02) :257-267
[6]   POTENTIATION OF EO9 ANTITUMOR-ACTIVITY BY HYDRALAZINE [J].
BIBBY, MC ;
SLEIGH, NR ;
LOADMAN, PM ;
DOUBLE, JA .
EUROPEAN JOURNAL OF CANCER, 1993, 29A (07) :1033-1035
[7]   THE LOGISTICS OF BROADER PRE-CLINICAL EVALUATION OF POTENTIAL ANTI-CANCER AGENTS WITH REFERENCE TO ANTI-TUMOR ACTIVITY AND TOXICITY OF MITOZOLOMIDE [J].
BIBBY, MC ;
DOUBLE, JA ;
WAHED, IA ;
HIRBAWI, N ;
BAKER, TG .
BRITISH JOURNAL OF CANCER, 1988, 58 (02) :139-143
[8]   FLAVONE ACETIC-ACID FROM LABORATORY TO CLINIC AND BACK [J].
BIBBY, MC ;
DOUBLE, JA .
ANTI-CANCER DRUGS, 1993, 4 (01) :3-17
[9]  
Boyd M. R., 1989, CANCER PRINCIPLES PR, V3, P1
[10]  
BRESALIER RS, 1987, CANCER RES, V47, P1398